Table 3b.
Baseline data | Follow-up data | |||||||
---|---|---|---|---|---|---|---|---|
Community | N | MDA History +ve |
MDA NVD +ve |
MDA Dipstick +ve |
N | MDA History +ve |
MDA NVD +ve |
MDA Dipstick +ve |
Abuator | 30 | C | C | C | 60 | S | S | S |
Obodo-Oyibo | 30 | S | C | C | 35 | - | - | S |
Lagos- Iyede | 30 | S | S | C | 60 | - | - | - |
Asafor Ase | 30 | - | - | S | 42 | - | - | - |
Umu Onyia | 30 | - | - | S | 52 | - | - | - |
Okpai-Oluchi | 30 | - | - | S | 60 | - | - | - |
Beneku | 30 | - | - | S | 60 | - | - | - |
Okolori-Afor | 30 | - | - | S | 34 | - | - | - |
C=Community wide MDA, S=School aged children MDA
NVD: Nurse Visual Diagnosis of Hematuria
Communities qualified for treatment of all school aged children if the prevalence of hematuria was ≥10% by any method in a sample of school aged children. Communities qualified for community wide treatment if the prevalence of hematuria and visual diagnosis or history was ≥50%